Home › Trial NCT03389126
Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment
- Trial IDNCT03389126
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorSeoul National University Hospital
- Enrollment30
- Start date2017-12-01
- ConditionsCarcinoma, Hepatocellular
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.